Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Clinical practice guideline and real-life practice in hepatocellular carcinoma: A Korean perspective
Myung Ji Goh, Dong Hyun Sinn, Jong Man Kim, et al.
Clinical and Molecular Hepatology (2023) Vol. 29, Iss. 2, pp. 197-205
Open Access | Times Cited: 22

Showing 22 citing articles:

Adjuvant and neoadjuvant immunotherapies in hepatocellular carcinoma
Josep M. Llovet, Roser Pinyol, Mark Yarchoan, et al.
Nature Reviews Clinical Oncology (2024) Vol. 21, Iss. 4, pp. 294-311
Closed Access | Times Cited: 106
Overview of Asian clinical practice guidelines for the management of hepatocellular carcinoma: An Asian perspective comparison
Yuri Cho, Bo Hyun Kim, Joong‐Won Park
Clinical and Molecular Hepatology (2023) Vol. 29, Iss. 2, pp. 252-262
Open Access | Times Cited: 41
A Phase I/IIa Trial of Yttrium-90 Radioembolization in Combination with Durvalumab for Locally Advanced Unresectable Hepatocellular Carcinoma
Yun Bin Lee, Joon Yeul Nam, Eun Ju Cho, et al.
Clinical Cancer Research (2023) Vol. 29, Iss. 18, pp. 3650-3658
Open Access | Times Cited: 25
Tips for Preparing and Practicing Thermal Ablation Therapy of Hepatocellular Carcinoma
Yasunori Minami, Tomoko Aoki, Satoru Hagiwara, et al.
Cancers (2023) Vol. 15, Iss. 19, pp. 4763-4763
Open Access | Times Cited: 19
High‐dose proton pump inhibitor treatment is associated with a higher mortality in cirrhotic patients: A multicentre study
Jun Sik Yoon, Ji Hoon Hong, Soo Young Park, et al.
Alimentary Pharmacology & Therapeutics (2024) Vol. 59, Iss. 8, pp. 973-983
Closed Access | Times Cited: 6
Epidemiological characteristics and precise prophylaxis and control of HBV-associated primary liver cancer
Yuqi Feng, Letian Fang, Guangwen Cao
Hepatoma Research (2025)
Open Access
A Prospective, Multicenter, Randomized, Noninferiority Trial of Stopad® Versus Tachosil® for Hemostasis After Liver Resection
Sung Yoon Lim, Gi Hong Choi, Jin Hong Lim, et al.
Cancers (2025) Vol. 17, Iss. 5, pp. 757-757
Open Access
Limited Generalizability of Retrospective Single-Center Cohort Study in Comparison to Multicenter Cohort Study on Prognosis of Hepatocellular Carcinoma
Ye Rim Kim, Sung Won Chung, Min-Ju Kim, et al.
Journal of Hepatocellular Carcinoma (2024) Vol. Volume 11, pp. 1235-1249
Open Access | Times Cited: 3
The Association Between Hepatocellular Carcinoma and Gastrointestinal Adenocarcinoma: Is This a New Syndrome in Patients With Cirrhosis? A Case Series
F. Bronte, Fabio D’Amato, Maria Rosa Barcellona, et al.
Cancer Reports (2025) Vol. 8, Iss. 5
Open Access
The current trends in the health burden of primary liver cancer across the globe
Peter Konyn, Aijaz Ahmed, Donghee Kim
Clinical and Molecular Hepatology (2023) Vol. 29, Iss. 2, pp. 358-362
Open Access | Times Cited: 8
A Real-World Comparative Analysis of Atezolizumab Plus Bevacizumab and Transarterial Chemoembolization Plus Radiotherapy in Hepatocellular Carcinoma Patients with Portal Vein Tumor Thrombosis
Soon Kyu Lee, Jung Hyun Kwon, Sung Won Lee, et al.
Cancers (2023) Vol. 15, Iss. 17, pp. 4423-4423
Open Access | Times Cited: 6
Analysis of Immune-Related Adverse Events of Atezolizumab and Bevacizumab in Patients with Hepatocellular Carcinoma: A Multicentre Cohort Study
Heechul Nam, Jaejun Lee, Ji Won Han, et al.
Liver Cancer (2023) Vol. 13, Iss. 4, pp. 413-425
Open Access | Times Cited: 6
Role of transarterial chemoembolization for hepatocellular carcinoma with extrahepatic metastases in the era of advancing systemic therapy
Byeong Geun Song, Myung Ji Goh, Wonseok Kang, et al.
Journal of Liver Cancer (2024) Vol. 24, Iss. 2, pp. 243-252
Open Access | Times Cited: 1
Primary treatments for solitary hepatocellular carcinoma ≤ 3 cm: A systematic review and network meta-analysis
Sang Hoon Kim, Ki‐Hun Kim, Byeong-Gon Na, et al.
Annals of Hepato-Biliary-Pancreatic Surgery (2024) Vol. 28, Iss. 4, pp. 397-411
Open Access
The position of loco-regional therapy in the management of hepatocellular carcinoma with extrahepatic metastases
Beom Kyung Kim
Journal of Liver Cancer (2024) Vol. 24, Iss. 2, pp. 129-130
Open Access
Neutrophil count predicts the complete response after transarterial chemoembolization related to favorable outcome in hepatocellular carcinoma
Young Mi Hong
European Journal of Gastroenterology & Hepatology (2024)
Closed Access
Importance of Early Detection and Prognostic Insights in Pediatric Hepatocellular Carcinoma: Findings from a Comprehensive Database Analysis
Sujin Gang, Pyeong Hwa Kim, Hyunhee Kwon, et al.
(2024)
Closed Access
What should be done to reduce the discrepancy between guidelines and real-life practice for hepatocellular carcinoma in Korea?
Min Kyung Park, Yoon Jun Kim
Clinical and Molecular Hepatology (2023) Vol. 29, Iss. 2, pp. 332-334
Open Access | Times Cited: 1
The Position of Multikinase Inhibitors in the Era of Immune-Checkpoint Inhibitors for Hepatocellular Carcinoma
Beom Kyung Kim
Gut and Liver (2024) Vol. 18, Iss. 1, pp. 3-4
Open Access
Role of reimbursement and Physicians' awareness in the survival of sorafenib‐eligible advanced hepatocellular carcinoma patients
Hui‐Ling Huang, Te‐Sheng Chang, Lariza Marie Canseco, et al.
The Kaohsiung Journal of Medical Sciences (2024) Vol. 40, Iss. 6, pp. 589-598
Open Access
Similar recurrence after curative treatment of HBV-related HCC, regardless of HBV replication activity
Mi Na Kim, Beom Kyung Kim, Heejin Cho, et al.
PLoS ONE (2024) Vol. 19, Iss. 8, pp. e0307712-e0307712
Open Access
Evolution of Liver Resection for Hepatocellular Carcinoma: Change Point Analysis of Textbook Outcome over Twenty Years
Yeshong Park, Ho‐Seong Han, Sung Yoon Lim, et al.
Medicina (2024) Vol. 61, Iss. 1, pp. 12-12
Open Access
Toward user-friendly and evidence-based practice guidelines for hepatocellular carcinoma
Do Young Kim
Clinical and Molecular Hepatology (2023) Vol. 29, Iss. 2, pp. 335-338
Open Access
Page 1

Scroll to top